
This retrospective analysis explored the impact of infertility health benefit design on the use of infertility medications and procedures and pregnancy outcomes.

This retrospective analysis explored the impact of infertility health benefit design on the use of infertility medications and procedures and pregnancy outcomes.

Employees with hepatitis C (HCV) who underwent existing treatments had more absences and higher indirect costs than HCVinfected employees who did not undergo treatment.

Antihypertensive medication adherence was associated with improvement in certain short-term utilization measures among employees with high prior medical costs.
